China Maintains “zero-COVID” Policy in Chengdu Despite Fatal 6.8 Magnitude Earthquake 07/09/2022 Raisa Santos Authorities in China’s southwestern city of Chengdu are sticking to the nation’s “zero-COVID” policy demanding a lockdown on the city’s 21 million inhabitants even in the face of a major earthquake that has killed at least 66 people in the region. Chengdu, the capital of China’s Sichuan province, has been beset by a heatwave and […] Continue reading -> WHO Warns Against ‘Complacency’ over COVID-19 and Monkeypox 07/09/2022 Kerry Cullinan Although COVID-19 and monkeypox cases are declining globally, World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus warned against complacency on Wednesday. Although COVID-19 cases were down by 80% since February, “last week, one person died with COVID-19 every 44 seconds and most of those those those deaths are avoidable,” said Tedros. “There is no […] Continue reading -> New Initiative Will Enable Speedy Introduction of COVID-19 Antivirals in Africa and Southeast Asia 07/09/2022 Kerry Cullinan A new initiative to introduce COVID-19 oral antivirals and national test-and-treat programmes in 10 countries in Africa and Southeast Asia was launched on Wednesday by the COVID Treatment Quick Start Consortium. The consortium will support governments to introduce and scale up access to antivirals, starting with Pfizer’s Paxlovid, in high-risk populations in Ghana, Kenya, Laos, […] Continue reading -> UN Approves High-Level Pandemic Summit 02/09/2022 John Heilprin The United Nations General Assembly voted to hold a summit of heads of state and other world leaders next year to find fair, long-lasting solutions for the global inequities and inadequate responses that the COVID-19 pandemic has all too painfully highlighted. Delegates to the 193-nation assembly overwhelmingly approved the resolution in a consensus vote on […] Continue reading -> US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> Swiss Approve 1st Booster for Variants 29/08/2022 John Heilprin Swiss drugs regulator Swissmedic announced it has temporarily authorized the first bivalent Covid-19 booster vaccine in the country. That clears the way for an eagerly anticipated second round of booster vaccinations that should better target Omicron sub-variants. Moderna’s COVID-19 mRNA-1273.214 vaccine, Spikevax, is the first COVID-19 vaccine that contains messenger ribonucleic acid (mRNA) against two […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> WHO Advocates Prevention Focus in Africa 23/08/2022 Paul Adepoju & John Heilprin African nations need to pivot to prevention in their fight against disease by “addressing its root causes” through a greater focus on improved diets, healthier environments, and better road safety, among other factors, WHO Director-General Dr Tedros Adhanom Ghebreyesus told the 72nd WHO Regional Committee for Africa meeting, at the opening of the weeklong session of […] Continue reading -> Posts navigation Older postsNewer posts
WHO Warns Against ‘Complacency’ over COVID-19 and Monkeypox 07/09/2022 Kerry Cullinan Although COVID-19 and monkeypox cases are declining globally, World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus warned against complacency on Wednesday. Although COVID-19 cases were down by 80% since February, “last week, one person died with COVID-19 every 44 seconds and most of those those those deaths are avoidable,” said Tedros. “There is no […] Continue reading -> New Initiative Will Enable Speedy Introduction of COVID-19 Antivirals in Africa and Southeast Asia 07/09/2022 Kerry Cullinan A new initiative to introduce COVID-19 oral antivirals and national test-and-treat programmes in 10 countries in Africa and Southeast Asia was launched on Wednesday by the COVID Treatment Quick Start Consortium. The consortium will support governments to introduce and scale up access to antivirals, starting with Pfizer’s Paxlovid, in high-risk populations in Ghana, Kenya, Laos, […] Continue reading -> UN Approves High-Level Pandemic Summit 02/09/2022 John Heilprin The United Nations General Assembly voted to hold a summit of heads of state and other world leaders next year to find fair, long-lasting solutions for the global inequities and inadequate responses that the COVID-19 pandemic has all too painfully highlighted. Delegates to the 193-nation assembly overwhelmingly approved the resolution in a consensus vote on […] Continue reading -> US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> Swiss Approve 1st Booster for Variants 29/08/2022 John Heilprin Swiss drugs regulator Swissmedic announced it has temporarily authorized the first bivalent Covid-19 booster vaccine in the country. That clears the way for an eagerly anticipated second round of booster vaccinations that should better target Omicron sub-variants. Moderna’s COVID-19 mRNA-1273.214 vaccine, Spikevax, is the first COVID-19 vaccine that contains messenger ribonucleic acid (mRNA) against two […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> WHO Advocates Prevention Focus in Africa 23/08/2022 Paul Adepoju & John Heilprin African nations need to pivot to prevention in their fight against disease by “addressing its root causes” through a greater focus on improved diets, healthier environments, and better road safety, among other factors, WHO Director-General Dr Tedros Adhanom Ghebreyesus told the 72nd WHO Regional Committee for Africa meeting, at the opening of the weeklong session of […] Continue reading -> Posts navigation Older postsNewer posts
New Initiative Will Enable Speedy Introduction of COVID-19 Antivirals in Africa and Southeast Asia 07/09/2022 Kerry Cullinan A new initiative to introduce COVID-19 oral antivirals and national test-and-treat programmes in 10 countries in Africa and Southeast Asia was launched on Wednesday by the COVID Treatment Quick Start Consortium. The consortium will support governments to introduce and scale up access to antivirals, starting with Pfizer’s Paxlovid, in high-risk populations in Ghana, Kenya, Laos, […] Continue reading -> UN Approves High-Level Pandemic Summit 02/09/2022 John Heilprin The United Nations General Assembly voted to hold a summit of heads of state and other world leaders next year to find fair, long-lasting solutions for the global inequities and inadequate responses that the COVID-19 pandemic has all too painfully highlighted. Delegates to the 193-nation assembly overwhelmingly approved the resolution in a consensus vote on […] Continue reading -> US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> Swiss Approve 1st Booster for Variants 29/08/2022 John Heilprin Swiss drugs regulator Swissmedic announced it has temporarily authorized the first bivalent Covid-19 booster vaccine in the country. That clears the way for an eagerly anticipated second round of booster vaccinations that should better target Omicron sub-variants. Moderna’s COVID-19 mRNA-1273.214 vaccine, Spikevax, is the first COVID-19 vaccine that contains messenger ribonucleic acid (mRNA) against two […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> WHO Advocates Prevention Focus in Africa 23/08/2022 Paul Adepoju & John Heilprin African nations need to pivot to prevention in their fight against disease by “addressing its root causes” through a greater focus on improved diets, healthier environments, and better road safety, among other factors, WHO Director-General Dr Tedros Adhanom Ghebreyesus told the 72nd WHO Regional Committee for Africa meeting, at the opening of the weeklong session of […] Continue reading -> Posts navigation Older postsNewer posts
UN Approves High-Level Pandemic Summit 02/09/2022 John Heilprin The United Nations General Assembly voted to hold a summit of heads of state and other world leaders next year to find fair, long-lasting solutions for the global inequities and inadequate responses that the COVID-19 pandemic has all too painfully highlighted. Delegates to the 193-nation assembly overwhelmingly approved the resolution in a consensus vote on […] Continue reading -> US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> Swiss Approve 1st Booster for Variants 29/08/2022 John Heilprin Swiss drugs regulator Swissmedic announced it has temporarily authorized the first bivalent Covid-19 booster vaccine in the country. That clears the way for an eagerly anticipated second round of booster vaccinations that should better target Omicron sub-variants. Moderna’s COVID-19 mRNA-1273.214 vaccine, Spikevax, is the first COVID-19 vaccine that contains messenger ribonucleic acid (mRNA) against two […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> WHO Advocates Prevention Focus in Africa 23/08/2022 Paul Adepoju & John Heilprin African nations need to pivot to prevention in their fight against disease by “addressing its root causes” through a greater focus on improved diets, healthier environments, and better road safety, among other factors, WHO Director-General Dr Tedros Adhanom Ghebreyesus told the 72nd WHO Regional Committee for Africa meeting, at the opening of the weeklong session of […] Continue reading -> Posts navigation Older postsNewer posts
US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> Swiss Approve 1st Booster for Variants 29/08/2022 John Heilprin Swiss drugs regulator Swissmedic announced it has temporarily authorized the first bivalent Covid-19 booster vaccine in the country. That clears the way for an eagerly anticipated second round of booster vaccinations that should better target Omicron sub-variants. Moderna’s COVID-19 mRNA-1273.214 vaccine, Spikevax, is the first COVID-19 vaccine that contains messenger ribonucleic acid (mRNA) against two […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> WHO Advocates Prevention Focus in Africa 23/08/2022 Paul Adepoju & John Heilprin African nations need to pivot to prevention in their fight against disease by “addressing its root causes” through a greater focus on improved diets, healthier environments, and better road safety, among other factors, WHO Director-General Dr Tedros Adhanom Ghebreyesus told the 72nd WHO Regional Committee for Africa meeting, at the opening of the weeklong session of […] Continue reading -> Posts navigation Older postsNewer posts
Swiss Approve 1st Booster for Variants 29/08/2022 John Heilprin Swiss drugs regulator Swissmedic announced it has temporarily authorized the first bivalent Covid-19 booster vaccine in the country. That clears the way for an eagerly anticipated second round of booster vaccinations that should better target Omicron sub-variants. Moderna’s COVID-19 mRNA-1273.214 vaccine, Spikevax, is the first COVID-19 vaccine that contains messenger ribonucleic acid (mRNA) against two […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> WHO Advocates Prevention Focus in Africa 23/08/2022 Paul Adepoju & John Heilprin African nations need to pivot to prevention in their fight against disease by “addressing its root causes” through a greater focus on improved diets, healthier environments, and better road safety, among other factors, WHO Director-General Dr Tedros Adhanom Ghebreyesus told the 72nd WHO Regional Committee for Africa meeting, at the opening of the weeklong session of […] Continue reading -> Posts navigation Older postsNewer posts
Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> WHO Advocates Prevention Focus in Africa 23/08/2022 Paul Adepoju & John Heilprin African nations need to pivot to prevention in their fight against disease by “addressing its root causes” through a greater focus on improved diets, healthier environments, and better road safety, among other factors, WHO Director-General Dr Tedros Adhanom Ghebreyesus told the 72nd WHO Regional Committee for Africa meeting, at the opening of the weeklong session of […] Continue reading -> Posts navigation Older postsNewer posts
NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> WHO Advocates Prevention Focus in Africa 23/08/2022 Paul Adepoju & John Heilprin African nations need to pivot to prevention in their fight against disease by “addressing its root causes” through a greater focus on improved diets, healthier environments, and better road safety, among other factors, WHO Director-General Dr Tedros Adhanom Ghebreyesus told the 72nd WHO Regional Committee for Africa meeting, at the opening of the weeklong session of […] Continue reading -> Posts navigation Older postsNewer posts
Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> WHO Advocates Prevention Focus in Africa 23/08/2022 Paul Adepoju & John Heilprin African nations need to pivot to prevention in their fight against disease by “addressing its root causes” through a greater focus on improved diets, healthier environments, and better road safety, among other factors, WHO Director-General Dr Tedros Adhanom Ghebreyesus told the 72nd WHO Regional Committee for Africa meeting, at the opening of the weeklong session of […] Continue reading -> Posts navigation Older postsNewer posts
WHO Advocates Prevention Focus in Africa 23/08/2022 Paul Adepoju & John Heilprin African nations need to pivot to prevention in their fight against disease by “addressing its root causes” through a greater focus on improved diets, healthier environments, and better road safety, among other factors, WHO Director-General Dr Tedros Adhanom Ghebreyesus told the 72nd WHO Regional Committee for Africa meeting, at the opening of the weeklong session of […] Continue reading -> Posts navigation Older postsNewer posts